These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10381137)

  • 1. In vitro effects of gonadotropin-releasing hormone (GnRH) analogue on cancer cell sensitivity to cis-platinum.
    Ohta H; Sakamoto H; Satoh K
    Cancer Lett; 1998 Dec; 134(1):111-8. PubMed ID: 10381137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of proliferation and up-regulation of apoptosis by gonadotropin-releasing hormone agonist in cultured uterine leiomyoma cells.
    Wang Y; Matsuo H; Kurachi O; Maruo T
    Eur J Endocrinol; 2002 Mar; 146(3):447-56. PubMed ID: 11888853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GnRH agonist inhibits human telomerase reverse transcriptase mRNA expression in endometrial cancer cells.
    Nagai N; Oshita T; Mukai K; Shiroyama Y; Shigemasa K; Ohama K
    Int J Mol Med; 2002 Nov; 10(5):593-7. PubMed ID: 12373298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of distinct gene expression profiles associated with treatment of LbetaT2 cells with gonadotropin-releasing hormone agonist using microarray analysis.
    Kakar SS; Winters SJ; Zacharias W; Miller DM; Flynn S
    Gene; 2003 Apr; 308():67-77. PubMed ID: 12711391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor.
    Chatzaki E; Bax CM; Eidne KA; Anderson L; Grudzinskas JG; Gallagher CJ
    Cancer Res; 1996 May; 56(9):2059-65. PubMed ID: 8616851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine role of gonadotropin-releasing hormone and its receptor in ovarian cancer cell growth.
    Kang SK; Cheng KW; Nathwani PS; Choi KC; Leung PC
    Endocrine; 2000 Dec; 13(3):297-304. PubMed ID: 11216641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
    Gründker C; Völker P; Schulz KD; Emons G
    Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells.
    Kiyozuka Y; Yamamoto D; Yang J; Uemura Y; Senzaki H; Adachi S; Tsubura A
    Anticancer Res; 2000; 20(1A):203-12. PubMed ID: 10769656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a GnRH analogue on human smooth muscle cells cultured from normal myometrial and from uterine leiomyomal tissues.
    Kobayashi Y; Zhai YL; Iinuma M; Horiuchi A; Nikaido T; Fujii S
    Mol Hum Reprod; 1997 Feb; 3(2):91-9. PubMed ID: 9239714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidomimetic GnRH antagonist AEZS-115 inhibits the growth of ovarian and endometrial cancer cells.
    Engel JB; Hahne JC; Häusler SF; Meyer S; Segerer SE; Diessner J; Dietl J; Honig A
    Anticancer Res; 2012 May; 32(5):2063-8. PubMed ID: 22593489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change of the expression of human telomerase reverse transcriptase mRNA and human telomerase RNA after cisplatin and 5-fluorouracil exposure in head and neck squamous cell carcinoma cell lines.
    Lee BJ; Lee BH; Wang SG; Lee JC; Roh HJ; Goh EK; Kim CM; Jun ES
    J Korean Med Sci; 2007 Sep; 22 Suppl(Suppl):S73-8. PubMed ID: 17923759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gonadotropin-releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor--positive human cancer cell lines.
    Pályi I; Vincze B; Kálnay A; Turi G; Mezõ I; Teplán I; Seprõdi J; Pató J; Móra M
    Cancer Detect Prev; 1996; 20(2):146-52. PubMed ID: 8706040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells.
    Segal-Abramson T; Kitroser H; Levy J; Schally AV; Sharoni Y
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2336-9. PubMed ID: 1312718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of endometrial cancer cell growth by luteinizing hormone (LH) and follicle stimulating hormone (FSH).
    Davies S; Bax CM; Chatzaki E; Chard T; Iles RK
    Br J Cancer; 2000 Dec; 83(12):1730-4. PubMed ID: 11104573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
    Gründker C; Völker P; Emons G
    Endocrinology; 2001 Jun; 142(6):2369-80. PubMed ID: 11356684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the messenger RNA for gonadotropin-releasing hormone and its receptor in human cancer cell lines.
    Yin H; Cheng KW; Hwa HL; Peng C; Auersperg N; Leung PC
    Life Sci; 1998; 62(22):2015-23. PubMed ID: 9627100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that prostate gonadotropin-releasing hormone receptors mediate an anti-tumourigenic response to analogue therapy in hormone refractory prostate cancer.
    Gnanapragasam VJ; Darby S; Khan MM; Lock WG; Robson CN; Leung HY
    J Pathol; 2005 Jun; 206(2):205-13. PubMed ID: 15818594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of GnRH receptor gene in human ectopic endometrial cells and inhibition of their proliferation by leuprolide acetate.
    Borroni R; Di Blasio AM; Gaffuri B; Santorsola R; Busacca M; Viganò P; Vignali M
    Mol Cell Endocrinol; 2000 Jan; 159(1-2):37-43. PubMed ID: 10687850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent effects of gonadotrophin-releasing hormone (GnRH) analogue and authentic GnRH on the anterior pituitary gland of rats with restricted feeding.
    Goto K; Kotsuji F; Tominaga T
    J Endocrinol; 1995 Jun; 145(3):501-11. PubMed ID: 7636434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: possible mechanism for hormonal control of apoptotic cell death.
    Imai A; Takagi A; Horibe S; Takagi H; Tamaya T
    J Clin Endocrinol Metab; 1998 Feb; 83(2):427-31. PubMed ID: 9467552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.